Trade AstraZeneca ^AZN

Faruqi & Faruqi Reminds AstraZeneca Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 21, 2025 - AZN By Investing.com

AstraZeneca PLC (NASDAQ:AZN) Holdings Lifted by Brookmont Capital Management

AstraZeneca PLC (NASDAQ:AZN) Shares Acquired by ZWJ Investment Counsel Inc.

AstraZeneca (AZN) Gets a Buy from Goldman Sachs

AstraZeneca PLC (NASDAQ:AZN) Receives Consensus Recommendation of "Buy" from Brokerages

Trinasolar Powers AstraZeneca's Sustainability Vision with Cutting-Edge Solar Carpark Rooftop Install | The Manila Times

AstraZeneca Faces Legal Challenges Amidst China Investigation

FDA approves Daiichi Sankyo's Trop-2 ADC for breast cancer | BioWorld

FDA Approves AstraZeneca, Daiichi Sankyo's Datroway for Previously Untreated Unresectable, Metastatic HR-Positive, HER2-Negative Breast Cancer

AstraZeneca PLC (NASDAQ:AZN) Shares Sold by LVW Advisors LLC

AstraZeneca And Daiichi Sankyo's Datroway Gets US Approval For Metastatic HR+ Breast Cancer | Markets Insider

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

Daiichi Sankyo rises most in five months on cancer drug approval - The Japan Times

AstraZeneca Secures FDA Nod for New ADC Drug Datroway in Breast Cancer - January 20, 2025 - Zacks.com

AstraZeneca PLC (NASDAQ:AZN) Shares Purchased by Veery Capital LLC

AstraZeneca's Fasenra set to revolutionise COPD treatment as Phase III data builds anticipation

AstraZeneca and Daiichi Sankyo win U.S. approval for breast cancer drug

Professional Advisory Services Inc. Raises Stake in AstraZeneca PLC (NASDAQ:AZN)

Procyon Advisors LLC Has $2.21 Million Stake in AstraZeneca PLC (NASDAQ:AZN)

23,847 Shares in AstraZeneca PLC (NASDAQ:AZN) Purchased by Empirical Asset Management LLC

FDA Okays AstraZeneca And Daiichi's Datroway For Metastatic HR-Positive, HER2-Negative Breast Cancer | Markets Insider

AstraZeneca PLC (NASDAQ:AZN) Short Interest Update

AstraZeneca's DATROWAY Receives FDA Approval for Advanced Breast Cancer Treatment

With COPD drug race nears finish line, AstraZeneca gearing to catch up GSK by presenting Phase 3 data

AstraZeneca's Datroway approved in U.S. for HER2-negative breast cancer patients

FDA Approves AstraZeneca's Calquence for Previously Untreated Mantle Cell Lymphoma

AstraZeneca PLC (AZN) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit | Morningstar

Boston Common Asset Management LLC Has $28.26 Million Stake in AstraZeneca PLC (OTCMKTS:AZNCF)

Channel Wealth LLC Boosts Stock Position in AstraZeneca PLC (NASDAQ:AZN)

Guggenheim lifts AstraZeneca stock target, buy rating on prospects By Investing.com

CALQUENCE® (acalabrutinib) plus chemoimmunotherapy approved in the US for patients with previously untreated mantle cell lymphoma | Morningstar

AstraZeneca PLC Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - AZN | Morningstar

FDA approves AstraZeneca's Calquence for untreated mantle cell lymphoma By Investing.com

AstraZeneca's Calquence gains FDA nod for 1L MCL treatment By Investing.com

AstraZeneca gains on getting nod from CDSCO to import new drug Eculizumab | Capital Market News - Business Standard

FDA approves new MCL treatment by AstraZeneca By Investing.com

AstraZeneca Pharma share price rises 3% on CDSCO nod for Eculizumab | News on Markets - Business Standard

AstraZeneca's rare disease portfolio gets a boost as company prepares to launch blockbuster drug in India

Kepler Capital Remains a Hold on AstraZeneca (AZN)

Pharma Stock Roundup: J&J's ITCI Buyout, LLY's Weak Q4 Sales - January 17, 2025 - Zacks.com

Calquence Plus Chemoimmunotherapy Approved in the U.S. for Patients with Previously Untreated Mantle Cell Lymphoma

ROSEN, LEADING INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN By Investing.com

Park Avenue Securities LLC Acquires 14,711 Shares of AstraZeneca PLC (NASDAQ:AZN)

AstraZeneca PLC (NASDAQ:AZN) Stock Position Reduced by Assenagon Asset Management S.A.

Pines Wealth Management LLC Invests $378,000 in AstraZeneca PLC (NASDAQ:AZN)

Chemistry, manufacturing and controls strategies for using novel excipients in lipid nanoparticles

Cellectis files to sell 44M ordinary shares for holders

Cox Capital Mgt LLC Grows Position in AstraZeneca PLC (NASDAQ:AZN)

Community Trust & Investment Co. Acquires 8,903 Shares of AstraZeneca PLC (NASDAQ:AZN)

Short Interest in AstraZeneca PLC (OTCMKTS:AZNCF) Expands By 116.7%

SpringWorks Therapeutics' SWOT analysis: biotech stock shows promise amid challenges By Investing.com

Is AstraZeneca (AZN) Top Stock Pick in Billionaire George Soros' Portfolio?

Trade Tracker: Jim Lebenthal buys Astrazeneca

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN By Investing.com

Tlwm Has $1.09 Million Stock Position in AstraZeneca PLC (NASDAQ:AZN)

Miracle Mile Advisors LLC Boosts Position in AstraZeneca PLC (NASDAQ:AZN)

J&J Says Lung Cancer Combo Improves Survival More Than Standard of Care